Newswise — Through the American Medical Group Association (AMGA) Department of Quality Management and Research, the American Medical Group Foundation (AMGF), and Daiichi Sankyo, Inc., the association is providing grants for quality improvement initiatives focusing on the management of hypertension. Medical groups, IPAs, academic practices, and integrated delivery systems that have successfully incorporated the management of hypertension into their chronic care models are encouraged to submit a case study for a compendium of best practices.
This is an opportunity for provider organizations to showcase their hypertension management initiatives and be recognized as leaders in innovative, high-quality patient care. Those selected to be included in the compendium will receive $2500 educational grants to support their quality improvement efforts.
AMGA is most interested in population-wide efforts, but will also consider case studies for particular high-risk patient groups. A panel of judges, consisting of physicians and quality improvement experts, will be looking for programs that have successfully incorporated the management of hypertension into care processes from small, medium, and large practices and meet the following criteria:
"¢ Care provided in an outpatient setting"¢ Patient care is coordinated across the continuum of services"¢ Program results in significant improvements in patient health"¢ Program engages the entire care team (doctors including generalists and specialists, nurses, administrative staff, pharmacy, patients, etc.)"¢ Program allows for efficient, ongoing measurement and reporting"¢ Project design is practical and addresses program goals"¢ Intervention(s) are transferable to other practice settings
Featured compendium groups will be announced at the AMGA 2008 Annual Conference, March 6-8, 2008 in Orlando, Florida.
Applications are due October 31, 2007. Guidelines are available at www.amga.org. For additional information, contact Danielle Flowers at d[email protected] or (703) 838-0033, ext. 347 or visit http://www.amga.org.
The American Medical Group Association (AMGA) represents medical groups, including some of the nation's largest, most prestigious integrated healthcare delivery systems. AMGA advocates for the multispecialty medical group model of healthcare delivery and for the patients served by medical groups through innovation and information sharing, benchmarking, leadership development, and continuous striving to improve patient care. The members of AMGA deliver health care to more than 50 million patients in 42 states, including 15 million capitated lives. Headquartered in Alexandria, Virginia, AMGA is the strategic partner for medical groups providing a comprehensive package of benefits, including political advocacy, educational and networking programs and publications, benchmarking data services, and financial and operations assistance. The American Medical Group Foundation is the philanthropic arm of the AMGA. As a nonprofit 501(C)3 organization, its mission is to foster quality improvement in group practice through education and research programs in clinical quality, patient safety, service, operational efficiency and innovation. For more information, visit www.amga.org.
Daiichi Sankyo, Inc., headquartered in Parsippany, New Jersey, is the U.S. subsidiary of Daiichi Sankyo Co., Ltd., Japan's second largest pharmaceutical company and a global leader in pharmaceutical innovation since 1899. The company is dedicated to the discovery, development and commercialization of innovative medicines that improve the lives of patients throughout the world.
The primary focus of Daiichi Sankyo's research and development is cardiovascular disease, including therapies for dyslipidemia, hypertension, diabetes, and acute coronary syndrome. The company is also pursuing the discovery of new medicines in the areas of glucose metabolic disorders, infectious diseases, cancer, bone and joint diseases, and immune disorders. For more information, please visit http://www.dsus.com.
RSS